The International Association for the Study of Lung Cancer (IASLC) shared a post on X:
“Discover insights from Dr Charu Aggarwal, Dr Sandip Patel, and Prof. Fernando Lopez-Rios at WCLC for a cross-disciplinary discussion exploring the future of diagnostic biomarker testing in NSCLC. This non-promotional symposium is organized and funded by AstraZeneca. For HCPs only.”
More posts featuring IASLC.